Background. Protein-energy wasting is tightly associated with mortality in haemodialysis patients. An expert panel of the International Society of Renal Nutrition and Metabolism (ISRNM) has published a consensus on the parameters that define protein-energy nutritional status and posed the question, 'which scoring system most effectively predicts outcome?' The aim of our study was therefore to develop a composite score of protein-energy nutritional status (cPENS) and to assess its prediction of all-cause mortality. Methods. We used the data of 560 haemodialysis patients participating in the CONvective TRAnsport STudy (CON-TRAST). All participants were followed for occurrence of death. Internationally recommended nutritional targets were used as components of the cPENS, including the subjective global assessment (target score ≥6), albumin (≥4.0 g/ dL), normalized protein nitrogen appearance (≥0.8 g/kg/ day), cholesterol (≥100 mg/dL), creatinine (≥10 mg/dL) and BMI (>23 kg/m 2 ). A Cox regression model was used to analyse the relation between different cPENS variants and mortality. Results. The median follow-up time was 1.4 years (max 4.2). One hundred and five patients (19%) died. A cPENS variant based on albumin, BMI, creatinine and the nPNA yielded the strongest relation with mortality (hazard ratio 0.63, 95% confidence interval 0.54-0.74, P < 0.001), after adjustments for confounders. Some of the individual parameters of the cPENS, notably albumin and creatinine, were related to mortality with similar strength and magnitude. Conclusions. In conclusion, albumin reflects mortality risk similarly to multiple nutritional parameters combined. This questions the clinical value of the proposed diagnostic criteria for protein-energy wasting.
Introduction
Mortality remains exceptionally high in haemodialysis patients and is closely related to malnutrition [1] [2] [3] . Protein-energy wasting is a more distinct description of malnutrition and has been defined by an expert panel of the International Society of Renal Nutrition and Metabolism (ISRNM) as a state of decreased body stores of protein and fat masses [4] . Although it is estimated that 10 to 70% of haemodialysis patients suffer from protein-energy wasting [5] [6] [7] , it is hard to assess its presence and degree. As no single clinically applicable parameter provides a conclusive indication of protein-energy nutritional status, international guidelines recommend the use of multiple nutritional markers [8, 9] . This introduces the need for a composite score that facilitates assessment. The ISRNM recently published a consensus statement defining which elements describe protein-energy nutritional status [4] . It describes four categories, serum chemistry, body mass, muscle mass and dietary intake, and poses the question, 'what scoring system predicts outcome most effectively [4] ?' Current composite scores do not integrate all mentioned categories [10] or include inflammatory markers to describe the malnutrition-inflammation syndrome [11] [12] [13] . The ISRNM, however, states that inflammatory markers should not be used to determine protein-energy nutritional status, as these parameters do not define protein-energy nutritional status [4] . A recent publication described joint associations of nutritional parameters with mortality risk [3] , and it has been shown that a combination of nutritional parameters provides an improved specificity for adverse prognosis [14] . As a composite score of protein-energy nutritional status (cPENS) may be a meaningful guidance to improve outcome, the aim of our study was to develop such a score and assess its prediction of all-cause mortality in a cohort of chronic haemodialysis patients.
Materials and methods

Patients and study design
This prospective study is based on the first 560 haemodialysis patients in the CONvective TRAnsport STudy (CONTRAST), who had completed at least 3 months of follow-up by January 2009 or had died during followup. They were enrolled from dialysis centres in The Netherlands (n = 26), Norway (n = 1) and Canada (n = 1). CONTRAST is an ongoing randomized controlled trial [ISRCTN38365125 (controlled-trials.com)] comparing low-flux haemodialysis and online haemodiafiltration with regard to all-cause mortality and cardiovascular events, as described elsewhere [15] . Inclusion criteria were treatment with haemodialysis two or three times per week, for at least 2 months, a minimum dialysis urea Kt/V ≥1.2 and the ability to understand the study procedures. Exclusion criteria were age <18 years, treatment by haemodiafiltration or high-flux haemodialysis in the 6 months preceding randomization, severe incompliance defined as non-adherence to the dialysis prescription, a life expectancy < 3 months due to morbidity other than kidney disease and participation in another clinical intervention trial evaluating cardiovascular outcome. The study was conducted in accordance with the Declaration of Helsinki and was approved by the medical ethics review boards of all participating hospitals. Written informed consent was obtained from all patients prior to randomization.
CONTRAST is still ongoing. The investigators who performed the statistical analyses were blinded to the allocation of treatment (haemodialysis or online haemodiafiltration) as they had access to a dataset without that information. As time-dependent measurements could have been affected by allocated treatment, only baseline levels of protein-energy nutritional status were analysed. To act as a confounder, treatment should be related to both exposure and outcome [16] . Since CONTRAST is a randomized clinical trial, protein-energy nutritional status is randomly distributed between both treatment groups. Thus, at baseline, nutritional status is not related to treatment and confounding by treatment is excluded. In addition, due to the ongoing adjudication process of fatal and non-fatal events in CONTRAST, the present analysis was restricted to all-cause mortality without providing cause-specific information.
Data collection
At baseline, standardized forms were used to collect demographical, clinical and laboratory data. Clinical characteristics studied were data on medical history, including the cause of kidney failure, the diabetic state and previous cardiovascular disease, vascular access, haemodialysis adequacy (Kt/V urea), time on kidney replacement therapy in years (dialysis vintage), treatment time in hours, blood pressure, residual kidney function (rGFR), statin use (yes/no), alcohol use (yes/no) and smoking habit (yes/no). The systolic and diastolic blood pressures reported are values prior to dialysis (mm Hg). Blood samples were drawn prior to dialysis for routine laboratory assessments. Samples for the determination of urea and creatinine were also drawn after the dialysis session. The samples were analysed in the local hospitals using standard techniques. Interdialytic urinary samples were collected in patients with a urinary production of 100 mL per day or more. In these patients, residual renal function was expressed as glomerular filtration rate (GFR), calculated as the mean of creatinine and urea clearance and adjusted for body surface area (mL/min/1.73 m 2 ) [9] . The second generation Daugirdas formula was used to calculate single pool Kt/V for urea [17] . The normalized protein nitrogen appearance (nPNA), also known as protein catabolic rate (nPCR), estimates the urea nitrogen appearance, which correlates with protein intake. The nPNA was calculated from two blood urea nitrogen measurements and adjusted for residual kidney urea clearance as described by Depner [18] . More detailed information on the study measurements can be found elsewhere [15] . Fatal events were reported immediately by the participating centres. Survival time was defined as the number of days between randomization and the date of death or the end of follow-up for this sub-study. There was no loss to follow-up as dropouts (e.g. because of transfer to a nonparticipating dialysis centre or switch to a renal replacement therapy other than haemodialysis or online haemodiafiltration) were still followed for mortality.
cPENS. Based on the recommendations of the ISRNM [4] , we assessed protein-energy nutritional status with serum albumin and serum cholesterol as parameters of serum chemistry, body mass index calculated with dry weight (BMI) to assess body mass, pre-dialysis serum creatinine to assess muscle mass and the nPNA to assess dietary intake. In addition, we used the seven-point subjective global assessment (SGA) to measure nutritional status by combining a medical history with a physical examination [19] . The medical history of the SGA examines weight change, dietary intake and gastrointestinal symptoms. The physical examination explores subcutaneous fat and muscle mass. To diagnose protein-energy wasting, the ISRNM describes cut-off values for serum albumin (<3.8 g/dL), cholesterol (<100 mg/dL), the nPNA (<0.8 g/kg/day) and BMI (<23 kg/m 2 ) [4] . International guidelines furthermore indicate cut-off values for serum creatinine (<10 mg/dL) and the SGA (<6) [8, 9] . Based on these target values, a composite score of protein-energy nutritional status (cPENS) was created. Several variations of the cPENS were evaluated to identify the one with the strongest relationship with mortality, for instance, by applying a weighted scoring or by leaving out nutritional parameters redundant for the determination of protein-energy nutritional status. The weighted scoring increased the influence of nutritional parameters with a relative stronger relation to mortality. The parameters were multiplied with a factor that represented their relative strength as a predictor of mortality, as compared to the nutritional parameter that showed the weakest hazard ratio. If cholesterol ≥100 mg/dL, for instance, had the weakest hazard ratio and the hazard ratio for albumin ≥3.8 g/dL was three times as strong, cholesterol would get a weight of 1 and albumin of 3. By means of sensitivity analysis, we also analysed cPENS variants with a double cut-off value for BMI (>23 to ≤26 kg/m 2 ) or cholesterol (≥150 to ≤200 mg/dL). BMI showed a nonlinear U-shaped relationship with outcome, and a non-linear relationship of cholesterol with mortality has been described [9] . We also explored variants that integrated continuous instead of dichotomous components while using standardized values of the nutritional parameters.
Data analysis
Patient characteristics were reported as means with standard deviations, medians with interquartile ranges or as proportions, when appropriate. Non-linear relationships between protein-energy nutritional parameters and mortality were examined using scatter plots with local regression ('smoothers'). Confounders were selected when they caused ≥5% change compared to the crude relation. Specific confounders were identified for each relation. All patient characteristics were treated as potential confounders, except serum urea which is mathematically related to nPNA. We used Cox regression analysis to estimate hazard ratios with 95% confidence intervals (CIs) for all-cause mortality. To compare the hazard ratios, the different nutritional parameters and composite score variants were standardized (value minus mean, divided by the standard deviation). When the CIs between the estimated relations of these variants with allcause mortality did not overlap, the difference was considered to be significant. Correlations between parameters of protein-energy nutritional status were analysed with Spearman's correlation coefficient. Results were considered statistically significant when P < 0.05 (two-tailed comparison). Missing values were imputed with single regression analysis [20] . All analyses were conducted using SPSS (version 15.0.1; SPSS Inc. Headquarters, Chicago, IL, USA).
Results
Patient characteristics
The characteristics of the 560 patients are summarized in Table 1 . The mean age was 64 ± 14 years and 62% of patients were male. Eighty-three percent had an SGA ≥6, i.e. well nourished, 88% had an nPNA ≥0.8 g/kg/day, 90% had a serum cholesterol of ≥100 mg/dL, 38% had a serum creatinine of ≥10 mg/dL, 65% had a BMI ≥23 kg/m 2 and 42% had a serum albumin of 3.8 g/dL or higher. The maximum follow-up time was 4.2 years (median 1.4 years, interquartile range 0.8-2.4). One hundred and five patients (19%) died from any cause during follow-up. There was no loss to follow-up.
The cPENS in relation to mortality Table 2 depicts the various variants of the cPENS, indicating that the score with the strongest hazard ratio combined albumin, BMI, creatinine and the nPNA on a weighted scale (variant 5). The addition of serum cholesterol or the SGA to the composite did not significantly improve its relation to mortality. The weighted score depicts protein-energy nutritional status on a scale from 0 to 7 (Table 3) . A score of 0 implies that no target values are met, and a score of 7 implies that all four target values are met. The crude hazard ratio on this scale was 0.69 (95% CI 0.62-0.78, P < 0.001) and when adjusted for identified confounders (age, gender and clinical centre) 0.63 (95% CI 0.54-0.74, P < 0.001). The influence of age on the crude hazard ratio was 5% (hazard ratio per year: 1.05; 1.03-1.07, P ≤ 0.001), of gender 5% (HR male versus female: 1.12; 0.73-1.70, P = 0.6) and clinical centre 7% (HR not depicted as there were multiple centres).
Sensitivity analyses showed that the strength of the relation between the cPENS and mortality did not significantly increase with a double cut-off value for BMI (>23 to ≤26 kg/m 2 ) or cholesterol (≥150 to ≤200 mg/dL) or continuous instead of dichotomous components (data not shown). Figure 1 depicts adjusted Cox survival curves per cPENS quartile. The number of patients and hazard ratios per quartile is shown in Table 4 .
The cPENS versus individual nutritional parameters
As a predictor of mortality, the cPENS did not perform better than some of its individual components (Table 5 ). a Albumin (≥3.8 g/dL), BMI after dialysis (≥23 kg/m 2 ), pre-dialysis creatinine (≥10 mg/dL), nPNA (normalized protein nitrogen appearance, ≥0.8 g/kg/day), cholesterol (≥100 mg/dL), SGA (subjective global assessment, target score ≥6). b The influence of individual components is based on the relative strength of their relation with mortality, taking the weakest association as a reference value (see Materials and methods section). All hazard ratios were adjusted for confounders that caused ≥5% change, as identified for every individual relation. Variant 5 was adjusted for age, gender and clinical centre. The score (influence) of the individual components is based on the relative strength of their relation with mortality, taking the weakest association as a reference value (see Materials and methods section). BMI, body mass index measured after dialysis; nPNA, normalized protein nitrogen appearance; Creatinine, pre-dialysis creatinine; cPENS, composite score of proteinenergy nutritional status. When the different parameters were standardized, the strength and magnitude of the hazard ratio of the cPENS were comparable to that of serum albumin and creatinine. The cPENS showed a strong correlation with most nutritional parameters (Table 6 ). Mutual correlations of the individual parameters were small to mediocre.
Discussion
Based on the recommendation of the ISRNM, we have created a composite score to assess protein-energy nutritional status. The cPENS includes four more readily available nutritional parameters: serum albumin, BMI, creatinine and the nPNA. The cPENS had a strong association with mortality, but as a predictor of outcome, it did not surpass serum albumin or creatinine. We are, to the best of our knowledge, the first to evaluate a composite score based on the international consensus on the elements that define protein-energy nutritional status [4] . Our results add evidence to answer the question, 'what scoring system of protein-energy wasting predicts outcome most effectively?', as posed by the ISRNM. It furthermore puts the clinical value of the proposed diagnostic criteria for protein-energy wasting to question.
Eighty-three percent of our cohort was well nourished according to the SGA, and on average, four of the six measured nutritional target levels were reached. Nutritional parameter levels were roughly in line with other large cohorts [2, 3, 21] . Serum cholesterol was lower in our patients as compared to the Hemodialysis study (HEMO: 173 ± 41; CONTRAST: 142 ± 38 mg/dL) [2] . This may be due to a possible higher use of lipid-lowering medication in our population. The predictive values of the different nutritional parameters were roughly comparable to other studies including HEMO [2, 21, 22] , but somewhat different as compared to DOPPS [3] . These differences are hard to explain as they do not point in one direction: the hazard ratio of BMI was somewhat lower in our population as compared to DOPPS, whereas the ratio of nPNA was comparable and the ratios of creatinine and albumin are somewhat stronger. The identified non-linear U-shaped relation of BMI to mortality has been described before in haemodialysis patients [23] .
The different cPENS variants showed comparable hazard ratios for mortality. SGA was significantly related to mortality in a multivariable Cox regression model, but it showed no added value to the cPENS as a predictor. Although the SGA is acknowledged as a potential marker of protein-energy nutritional status by the expert panel of the ISRNM, there is no consensus on the mutual relationship [4] . The ex- All hazard ratios were adjusted for confounders that caused ≥5% change, which were identified for every individual relation. SGA, subjective global assessment; BMI, post-dialysis body mass index; Creatinine, pre-dialysis creatinine; nPNA, normalized protein nitrogen appearance; cPENS, composite score of protein-energy nutritional status. A limitation of this study is that, as CONTRAST is still ongoing, we could only analyse baseline levels of proteinenergy nutritional status whereas repeated measures are recommended. As explained in the Materials and methods section, time-dependent measurements could have been affected by allocated treatment. By using only baseline data, confounding by treatment was not possible in the current analysis. Second, it might be that the difference in strength of the association between the cPENS and the individual parameters is due to a more restricted variability in the composite score as compared to the individual parameters. Our results may, for instance, be affected by the relatively preferable protein-energy nutritional status of our population with less variance around the cut-off value of SGA as compared to serum creatinine and albumin. The nutritional parameters are, however, roughly in line with other large cohorts as mentioned earlier [2, 3, 21] . A final limitation is the possibility of bias due to unmeasured confounding. Adjustment for measured confounders like age and gender did, however, not result in distinct changes.
At present it is difficult to measure protein-energy nutritional status in daily practice. A composite score of proteinenergy nutritional status may facilitate this assessment. Our results contribute evidence to the development of such a score, but it should be noted that composition and weighting should be evaluated in different populations.
Interactions between nutritional parameters have been described [3] , but whereas the correlations between nutritional parameters in our population were mild to mediocre, the correlations with the cPENS were predominantly strong. Future studies should compare a scoring system of protein-energy nutritional status with a reference standard of protein-energy nutritional status like total body nitrogen [24] to assess its validity as well as its ability to measure change over time in response to interventions.
Conclusion
Based on the consensus of the ISRNM, we evaluated several composite scores of protein-energy nutritional status. The proposed cPENS has a strong relation to mortality, but it is of similar strength and magnitude as serum albumin and creatinine. As determination of albumin alone reflects mortality risk similar to multiple nutritional markers combined, our results question the clinical value of the proposed diagnostic criteria for protein-energy wasting [4] with regard to outcome. Future studies should evaluate if a composite score with less readily available nutritional parameters has a superior relation to mortality.
